Genetics Pharmaceuticals products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Lahore · Pakistan
Lahore pharmaceutical manufacturer with major focus areas including neuropsychiatry, cardiometabolic care, child care and reproductive health.
Genetics Pharmaceuticals products in Pakistan
Genetics Pharmaceuticals Pvt. Ltd has 108 medicine presentations registered in Pakistan under 34 brands, covering 32 generic medicines. Most of its products are in CNS & mental health, Anti-infectives and Gastrointestinal & hepatology. Its brands with the most registered strengths and packs are Vepridone (Risperidone), Lepsi (Levetiracetam), Lamitor (Lamotrigine =) and Genset (Ondansetron). 108 products have an official DRAP price on MedInfoBase. See all 34 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Genetics Pharmaceuticals (Pvt.) Limited
- Company type
- Private pharmaceutical manufacturer
- Address
- 539-A, Sundar Industrial Estate, Raiwind Road, Lahore, Pakistan
- Phone
- +92 42 35297760-68
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 88%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Genetics Pharmaceuticals Pvt. Ltd is priced against the market
83 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Altavir | Oseltamivir | 75 mg | Capsule | 10's | 095671 | PKR 1,456.10 | PKR 145.61/capsule | 🔒 Pharma Pro |
| Apres 12.5mg TabletRegistry verified | Aprocitentan | — | — | — | 133903Official source ↗ | No indexed price | — | — |
| Aviclor-H | Hydroxychloroquine | 200 mg | Tablet | 30's | 101894 | PKR 498.58 | PKR 16.62/tablet | 🔒 Pharma Pro |
| Candizol | Fluconazole | 50 mg | Capsule | 7's | 085113 | PKR 897.60 | PKR 128.23/capsule | 🔒 Pharma Pro |
| Candizol | Fluconazole | 150 mg | Capsule | 1's | 085114 | PKR 282.98 | PKR 282.98/capsule | 🔒 Pharma Pro |
| Candizol | Fluconazole | 200 mg | Capsule | 4's | 085115 | PKR 984.28 | PKR 246.07/capsule | 🔒 Pharma Pro |
| Choligene | Colistimethate sodium | 150 mg | Injection | 1s | 121517 | PKR 4,501.60 | PKR 4,501.60/vial/unit | 🔒 Pharma Pro |
| Choligene | Colistimethate sodium | 68 mg | Injection | 1s | 121518 | PKR 2,000.07 | PKR 2,000.07/vial/unit | No comparator |
| Choligene | Colistimethate sodium | 34 mg | Injection | 1s | 121519 | PKR 1,199.81 | PKR 1,199.81/vial/unit | No comparator |
| Codopa | Carbidopa + Levodopa | 25 mg + 100 mg | Tablet | 100's | 104759 | PKR 1,170.86 | PKR 11.71/tablet | 🔒 Pharma Pro |
| Codopa | Carbidopa + Levodopa | 25 mg + 250 mg | Tablet | 100's | 104760 | PKR 1,974.71 | PKR 19.75/tablet | 🔒 Pharma Pro |
| Codopa 25/100mg | Carbidopa + Levodopa | 25 mg + 100 mg | Tablet | 30's, | 104759 | PKR 351.06 | — | No comparator |
| Codopa 25/250mg | Carbidopa + Levodopa | 25 mg + 250 mg | Tablet | 30's, | 104760 | PKR 644.27 | — | No comparator |
| Coviquine | Chloroquine | 250 mg | Tablet | 500's | 102670 | PKR 797.14 | PKR 1.59/tablet | 🔒 Pharma Pro |
| Diblay-M 12.5/850mg TabletRegistry verified | Empagliflozin, Metformin HCl | — | — | — | 135718Official source ↗ | No indexed price | — | — |
| Dualvir | Lopinavir + Ritonavir | 200 mg + 50 mg | Tablet | 120's | 104636 | PKR 16,080.37 | PKR 134.00/tablet | 🔒 Pharma Pro |
| Genset | Ondansetron | 8 mg | Tablet | 10s | 121766 | PKR 1,776.13 | PKR 177.61/tablet | 🔒 Pharma Pro |
| Genset | Ondansetron | 4 mg | Tablet | 10s | 121767 | PKR 1,065.68 | PKR 106.57/tablet | 🔒 Pharma Pro |
| Genset | Ondansetron | 8 mg/4 mL | Injection | 5s x 4mL Ampoule | 121768 | PKR 5,156.19 | — | No comparator |
| Genset | Ondansetron | 8 mg/4 mL | Injection | 1s x 4mL Ampoule | 121768 | PKR 1,031.24 | — | No comparator |
| Genset | Ondansetron | 4 mg/2 mL | Injection | 5s x 2mL Ampoule | 121769 | PKR 2,885.81 | — | No comparator |
| Genset | Ondansetron | 4 mg/2 mL | Injection | 1s x 2mL Ampoule | 121769 | PKR 577.76 | — | No comparator |
| Genset | Ondansetron | 4 mg/2 mL | Syrup | 50mL | 121770 | PKR 1,032.63 | PKR 20.65/mL | No comparator |
| Genxone | Ceftriaxone | 500 mg | IM injection | 1's | 117519 | PKR 351.10 | PKR 351.10/vial/unit | 🔒 Pharma Pro |
| Genxone | Ceftriaxone | 250 mg | Dry powder for injection | 1's | 117578 | PKR 208.59 | PKR 208.59/vial/unit | 🔒 Pharma Pro |
| Genxone | Ceftriaxone | 250 mg | Dry powder for injection | 1's | 117579 | PKR 208.59 | PKR 208.59/vial/unit | 🔒 Pharma Pro |
| Genxone | Ceftriaxone | 500 mg | IV injection | 1's | 117580 | PKR 351.10 | PKR 351.10/vial/unit | 🔒 Pharma Pro |
| Genxone | Ceftriaxone | 1 g | Dry powder for injection | 1's | 117581 | PKR 662.95 | PKR 662.95/vial/unit | 🔒 Pharma Pro |
| Genxone | Ceftriaxone | 1 g | Dry powder for injection | 1's | 117582 | PKR 662.95 | PKR 662.95/vial/unit | 🔒 Pharma Pro |
| Genxone | Ceftriaxone | 2 g | Dry powder for injection | 1's | 117583 | PKR 929.37 | PKR 929.37/vial/unit | 🔒 Pharma Pro |
| Geofor | Metformin | 500 mg | Extended-release tablet | 50's | 098481 | PKR 148.92 | PKR 2.98/tablet | 🔒 Pharma Pro |
| Geofor | Metformin | 1000 mg | Extended-release tablet | 50's | 110866 | PKR 697.86 | PKR 13.96/tablet | 🔒 Pharma Pro |
| Geofor | Metformin | 1000 mg | Extended-release tablet | 30's | 110866 | PKR 418.15 | PKR 13.94/tablet | 🔒 Pharma Pro |
| Geoxit | Fluoxetine | 20 mg | Capsule | 10's | 091404 | PKR 126.20 | PKR 12.62/capsule | 🔒 Pharma Pro |
| Idebeol | Empagliflozin | 10 mg | Tablet | 14's | 116405 | PKR 1,261.95 | PKR 90.14/tablet | 🔒 Pharma Pro |
| Idebeol | Empagliflozin | 25 mg | Tablet | 14's | 116406 | PKR 1,510.46 | PKR 107.89/tablet | 🔒 Pharma Pro |
| Infuvex | Linezolid | 600 mg | Tablet | 12's | 098482 | PKR 4,719.87 | PKR 393.32/tablet | 🔒 Pharma Pro |
| Iogen | Potassium iodide | 130 mg | Tablet | 20's | 111869 | PKR 54.51 | PKR 2.73/tablet | 🔒 Pharma Pro |
| Iogen | Potassium iodide | 65 mg | Tablet | 20's | 111870 | PKR 39.50 | PKR 1.98/tablet | 🔒 Pharma Pro |
| Konten | Losartan | 25 mg | Tablet | 20's | 099118 | PKR 203.12 | PKR 10.16/tablet | 🔒 Pharma Pro |
| Konten | Losartan | 50 mg | Tablet | 20's | 099119 | PKR 369.32 | PKR 18.47/tablet | 🔒 Pharma Pro |
| Konten | Losartan | 100 mg | Tablet | 10's | 099120 | PKR 369.32 | PKR 36.93/tablet | 🔒 Pharma Pro |
| Lamitor | Lamotrigine = | 25 mg | Tablet | 30's | 084100 | PKR 617.95 | PKR 20.60/tablet | 🔒 Pharma Pro |
| Lamitor | Lamotrigine = | 100 mg | Tablet | 30's | 084101 | PKR 1,029.91 | PKR 34.33/tablet | 🔒 Pharma Pro |
| Lamitor | Lamotrigine = | 200 mg | Tablet | 30's | 084102 | PKR 1,441.88 | PKR 48.06/tablet | 🔒 Pharma Pro |
| Lamitor | Lamotrigine = | 50 mg | Tablet | 30's | 085168 | PKR 823.93 | PKR 27.46/tablet | 🔒 Pharma Pro |
| Lamitor | Lamotrigine = | 250 mg | Tablet | 28's | 090113 | PKR 1,682.88 | PKR 60.10/tablet | No comparator |
| Lamitor | Lamotrigine = | 250 mg | Tablet | 10's, | 090113 | PKR 601.47 | — | No comparator |
| Lamitor | Lamotrigine = | 250 mg | Tablet | 14's, | 090113 | PKR 840.41 | — | No comparator |
| Lamitor | Lamotrigine = | 250 mg | Tablet | 20's, | 090113 | PKR 1,200.88 | — | No comparator |
All 34 Genetics Pharmaceuticals brands in Pakistan
- Altavir Oseltamivir · 75 mg capsule
- Aviclor-H Hydroxychloroquine · 200 mg tablet
- Candizol Fluconazole · 150 mg capsule, 200 mg capsule, 50 mg capsule
- Choligene Colistimethate sodium · 150 mg injection, 34 mg injection, 68 mg injection
- Codopa Carbidopa + Levodopa · 25 mg + 100 mg tablet, 25 mg + 250 mg tablet
- Codopa 25/100mg Carbidopa + Levodopa · 25 mg + 100 mg tablet
- Codopa 25/250mg Carbidopa + Levodopa · 25 mg + 250 mg tablet
- Coviquine Chloroquine · 250 mg tablet
- Dualvir Lopinavir + Ritonavir · 200 mg + 50 mg tablet
- Genset Ondansetron · 4 mg tablet, 4 mg/2 mL injection, 4 mg/2 mL syrup
- Genxone Ceftriaxone · 1 g injection, 2 g injection, 250 mg injection
- Geofor Metformin · 1000 mg tablet, 500 mg tablet
- Geoxit Fluoxetine · 20 mg capsule
- Idebeol Empagliflozin · 10 mg tablet, 25 mg tablet
- Infuvex Linezolid · 600 mg tablet
- Iogen Potassium iodide · 130 mg tablet, 65 mg tablet
- Konten Losartan · 100 mg tablet, 25 mg tablet, 50 mg tablet
- Lamitor Lamotrigine = · 100 mg tablet, 200 mg tablet, 25 mg tablet
- Lepsi Levetiracetam · 100 mg/mL solution, 250 mg tablet, 500 mg tablet
- Lithotrope SR Lithium carbonate · 400 mg tablet
- Navilox Moxifloxacin · 400 mg tablet
- Neuprofen Ibuprofen · 400 mg/4 mL injection
- Penfors Meropenem · 1 g injection, 500 mg injection
- Prequel Quetiapine · 100 mg tablet, 200 mg tablet, 25 mg tablet
- Prequel XR Quetiapine · 150 mg tablet, 200 mg tablet, 300 mg tablet
- Revalp Divalproex sodium, Valproic acid · 250 mg tablet, 500 mg tablet, 500 mg/5 mL injection
- Rivofos Sofosbuvir · 400 mg tablet
- Seredol Haloperidol · 1.5 mg tablet, 10 mg tablet, 5 mg tablet
- Tazipera Piperacillin + tazobactam · 4 g + 0.5 g injection
- Termigen Levofloxacin · 250 mg tablet, 500 mg tablet
- Triaxogen Cefixime · 100 mg/5 mL suspension, 200 mg/5 mL suspension, 400 mg capsule
- Vepridone Risperidone · 1 mg tablet, 2 mg tablet, 3 mg tablet
- Vivox Naltrexone · 50 mg tablet
- Zithrolide Azithromycin · 250 mg capsule, 500 mg tablet
Genetics Pharmaceuticals: common questions
How many products does Genetics Pharmaceuticals have in Pakistan?
Genetics Pharmaceuticals Pvt. Ltd has 108 registered medicine presentations in Pakistan, sold under 34 brands and covering 32 generic medicines.
What are the main brands of Genetics Pharmaceuticals?
By number of registered strengths and packs, its largest brands are Vepridone (Risperidone), Lepsi (Levetiracetam), Lamitor (Lamotrigine =), Genset (Ondansetron) and Genxone (Ceftriaxone). This is not a sales ranking.
Which therapy areas does Genetics Pharmaceuticals cover?
The most products are in CNS & mental health (59), Anti-infectives (31), Gastrointestinal & hepatology (7), Endocrine & metabolic (5) and Cardiovascular (3).
Where can I see Genetics Pharmaceuticals medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.